Information Journal Paper
APA:
Copy. (2018). Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?. MICROVASCULAR RESEARCH, 119(-), 7-12. SID. https://sid.ir/paper/681283/en
Vancouver:
Copy. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?. MICROVASCULAR RESEARCH[Internet]. 2018;119(-):7-12. Available from: https://sid.ir/paper/681283/en
IEEE:
Copy, “Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?,” MICROVASCULAR RESEARCH, vol. 119, no. -, pp. 7–12, 2018, [Online]. Available: https://sid.ir/paper/681283/en